New Medication for PTSD Approved

The double-blind, phase 3 trial included 416 adults aged 18-65 years with a DSM-5 diagnosis of PTSD and symptoms for at least 6 months prior to screening.

Patients underwent a 1-week placebo-run in period followed by randomization to daily oral brexpiprazole 2-3 mg plus sertraline 150 mg or daily sertraline 150 mg plus placebo for 11 weeks.

Comments

• Although the editors of BipolarNews.org have made every effort to report accurate information, much of the work referenced here is in abstract or pre-publication form, and may not have received proper review by the scientific community at this time. Patients should consult with their physicians about any treatment decisions. Physicians should consult the peer-reviewed literature.

• Recent Posts

  • Dextromethorphan potentiates the anti-depressant effects of SSRIs
  • New Medication for PTSD Approved
  • Psilocybin Bests SSRI for Major Depression in First Long-Term Comparison
  • Family History of Alcohol Dependence Predicts Antidepressant Response to an NMDA Antagonist
  • Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia

• Categories

  • A – Very Important and Reading for Consideration
  • About the BNN
  • B – Clinically Important for Future Consideration
  • Brain Imaging
  • C – May become important in the future
  • Comorbidities
  • Course of Illness
  • COVID-19
  • Current Treatments
  • Diagnosis
  • Genetics
  • Neurobiology
  • Neurochemistry
  • Peer-Reviewed Published Data
  • Political Commentary
  • Potential Treatments
  • Resources
  • Risk Factors
  • Theory

• Tags

  ADHD adolescents animal models antidepressant antidepressants anxiety autism BDNF bipolar depression bipolar disorder brain volume cardiovascular disease children cocaine cognition dementia depression diabetes epigenetics exercise family history genetics IL-6 inflammation ISBD 2023 ketamine lithium mania marijuana memory N-acetylcysteine nutrition obesity omega-3 fatty acids pregnancy ptsd rTMS schizophrenia side effects stress suicide treatment-resistance unipolar vitamin D white matter

• Archives

  • February 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • June 2024
  • May 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • March 2022
  • February 2022
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • May 2017
  • April 2017
  • March 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • February 2011
  • January 2011
  • November 2010
  • October 2010
  • July 2010
  • June 2010
  • April 2010
  • May 2009

• Blogroll

  • Bipolar Disorder at Medline Plus
  • Child and Adolescent Bipolar Foundation
  • DANA Foundation
  • Depression and Bipolar Support Alliance
  • International Society for Bipolar Disorders
  • Juvenile Bipolar Research Foundation
  • My Mood Monitor
  • NARSAD (National Alliance for Research on Schizophrenia and Depression)
  • National Alliance for the Mentally Ill
  • Psychiatric News
  • Social Security and Disability Resource Center